Transmedics Group Inc (NASDAQ: TMDX) is 75.51% higher on its value in year-to-date trading and has touched a low of $36.42 and a high of $154.75 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TMDX stock was last observed hovering at around $147.78 in the last trading session, with the day’s loss setting it -9.25%.
Currently trading at $138.53, the stock is -4.81% and 1.76% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.82 million and changing -6.26% at the moment leaves the stock 56.78% off its SMA200. TMDX registered 60.24% gain for a year compared to 6-month gain of 74.71%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 0.98% loss in the last 1 month and extending the period to 3 months gives it a 48.58%, and is -7.01% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.19% over the week and 4.76% over the month.
Transmedics Group Inc (TMDX) has around 584 employees, a market worth around $4.56B and $296.92M in sales. Fwd P/E is 118.74. Profit margin for the company is -3.43%. Distance from 52-week low is 280.37% and -10.48% from its 52-week high. The company has generated returns on investments over the last 12 months (-1.51%).
The EPS is expected to grow by 206.12% this year
The shares outstanding are 32.67M, and float is at 31.79M with Short Float at 18.81%.
Transmedics Group Inc (TMDX) Insider Activity
The most recent transaction is an insider sale by Khayal Tamer I, the company’s Chief Commercial Officer. SEC filings show that Khayal Tamer I sold 2,958 shares of the company’s common stock on Jul 01 ’24 at a price of $151.40 per share for a total of $0.45 million. Following the sale, the insider now owns 20843.0 shares.
Transmedics Group Inc disclosed in a document filed with the SEC on Jun 14 ’24 that Hassanein Waleed H (President & CEO) sold a total of 8,625 shares of the company’s common stock. The trade occurred on Jun 14 ’24 and was made at $141.85 per share for $1.22 million. Following the transaction, the insider now directly holds 61643.0 shares of the TMDX stock.
Still, SEC filings show that on Jun 05 ’24, Basile Edward M (Director) disposed off 1,193 shares at an average price of $138.08 for $0.16 million. The insider now directly holds 732 shares of Transmedics Group Inc (TMDX).
